BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5059641)

  • 1. Immunosuppressive therapy: guidelines for drug dosage. Depression of bone marrow granulocyte reserves in systemic lupus erythematosus.
    Paulus HE; Okun R; Calabro JJ
    Arthritis Rheum; 1972; 15(1):29-35. PubMed ID: 5059641
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of lupus nephritis with prednisone and combined prednisone and azathioprine.
    Donadio JV; Holley KE; Wagoner RD; Ferguson RH; McDuffie FC
    Ann Intern Med; 1972 Dec; 77(6):829-35. PubMed ID: 4566283
    [No Abstract]   [Full Text] [Related]  

  • 3. Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients.
    Hahn BH; Kantor OS; Osterland CK
    Ann Intern Med; 1975 Nov; 83(5):597-605. PubMed ID: 1106277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azathioprine and prednisone in the treatment of adults with lupus nephritis. Clinical, histological, and immunological changes with therapy.
    Drinkard JP; Stanley TM; Dornfeld L; Austin RC; Barnett EV; Pearson CM; Vernier RL; Adams DA; Latta H; Gonick HC
    Medicine (Baltimore); 1970 Sep; 49(5):411-32. PubMed ID: 4924695
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis.
    Steinberg AD; Decker JL
    Arthritis Rheum; 1974; 17(6):923-37. PubMed ID: 4611431
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of azathioprine, prednisone, and heparin alone or combined in treating lupus nephritis.
    Cade R; Spooner G; Schlein E; Pickering M; DeQuesada A; Holcomb A; Juncos L; Richard G; Shires D; Levin D; Hackett R; Free J; Hunt R; Fregly M
    Nephron; 1973; 10(1):37-56. PubMed ID: 4695164
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunopathological changes during immunosuppressive treatment of glomerulonephritis in systemic lupus erythematosus.
    Munthe E; Brodwall EK; Oyri A; Natvig JB
    Acta Med Scand; 1974 Oct; 196(4):291-9. PubMed ID: 4139879
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of azathioprine on lupus glomerulonephritis.
    Hayslett JP; Kashgarian M; Cook CD; Spargo BH
    Medicine (Baltimore); 1972 Sep; 51(5):393-412. PubMed ID: 4115512
    [No Abstract]   [Full Text] [Related]  

  • 9. Overview of treatment of lupus nephropathy.
    Coggins CH
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):197-200. PubMed ID: 7102668
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of lupus nephritis.
    Pollak VE
    Adv Nephrol Necker Hosp; 1976; 6():137-61. PubMed ID: 828444
    [No Abstract]   [Full Text] [Related]  

  • 11. Irreversible bone marrow failure with chlorambucil.
    Rudd P; Fries JF; Epstein WV
    J Rheumatol; 1975 Dec; 2(4):421-9. PubMed ID: 1206673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic studies in NZB-W mice. I. Synergy of azathioprine, cyclophosphamide and methylprednisolone in combination.
    Gelfand MC; Steinberg AD; Nagle R; Knepshield JH
    Arthritis Rheum; 1972; 15(3):239-46. PubMed ID: 5031608
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of treatment with enkorton and cytostatics on selected immunologic indicators in patients with systemic lupus erythematosus].
    Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Jedryka-Góral A; Swierczyńska Z; Rdułtowska H; Luft S; Rogozińska E
    Reumatologia; 1982; 20(1-2):7-14. PubMed ID: 7163667
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppressive therapy of proliferative glomerulonephritis in children.
    Urizar RE; Tinglof B; McIntosh R; Litman N; Barnett E; Wilkerson J; Smith F; Vernier RL
    Am J Dis Child; 1969 Sep; 118(3):411-25. PubMed ID: 4896973
    [No Abstract]   [Full Text] [Related]  

  • 15. Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis.
    Dinant HJ; Decker JL; Klippel JH; Balow JE; Plotz PH; Steinberg AD
    Ann Intern Med; 1982 Jun; 96(6 Pt 1):728-36. PubMed ID: 7046543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive drugs plus prednisone versus prednisone alone in lupus nephritis.
    N Engl J Med; 1985 Apr; 312(14):921-2. PubMed ID: 3974677
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of etiocholanolone for the measurement of marrow granulocyte reserves.
    Gunz FW; Mani MK; Ravich RB; Speden J; Vincent PC
    Med J Aust; 1970 Apr; 1(15):763-7. PubMed ID: 4914293
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunosuppressive long term therapy of visceral lupus erythematosus].
    Schubert JC; Schubert H; Holtz G; Martin H
    Dtsch Med Wochenschr; 1970 Aug; 95(35):1768-74. PubMed ID: 4195000
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of combined immunosuppressive treatment with Imuran and prednisone on the concentration of selected immune proteins in the serum of patients with lupus erythematosus].
    Chwal Z
    Pol Tyg Lek; 1976 May; 31(16):659-61. PubMed ID: 1083976
    [No Abstract]   [Full Text] [Related]  

  • 20. The course of lupus nephritis: contribution of serial renal biopsies.
    Morel-Maroger L; Méry JP; Droz D; Godin M; Verroust P; Kourilsky O; Richet G
    Adv Nephrol Necker Hosp; 1976; 6():79-118. PubMed ID: 139084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.